will launch the first-ever publicly available data and interactive maps of PrEP users by state from 2012 through 2016, overall and stratified by sex and age.

There is a Launch Toolkit for you to access and share social media content, infographics, a video, and other launch materials to help get the word out about AIDSVu’s new maps and resources.  There is also an AIDSVu public webinar, which will take place on Thursday, Mar. 8 at 1:00 pm ET.

Public Briefing Information:

  • Date and Time: Thursday, Mar. 8, 1:00 PM ET
  • Webinar link:
  • Dial-in: (701) 801-1211
  • Attendee access code: 506-325-060

Updated the data methods section with the following clarifications:

Data on PrEP users displayed on AIDSVu were obtained from Source Healthcare Analytics, LLC (SHA) with the support of Gilead Sciences, Inc., and compiled by researchers at the Rollins School of Public Health at Emory University. SHA provided Gilead with national, electronic, patient-level prescription data from an overall sample that represents over 54,000 pharmacies, 1,500 hospitals, 800 outpatient facilities, and 80,000 physician practices. This is an open sample of commercially available data, which excludes entities that do not make their data available, such as closed health care systems. All patient-level prescription data were de-identified and linked to confirmatory data from a de-identified medical insurance claims database. Gilead then utilized a validated algorithm to exclude prescriptions for TDF/FTC that were made for other known indications, such as HIV treatment, post-exposure prophylaxis, and chronic hepatitis B management. Through a data sharing agreement between SHA, Gilead, and Emory University, Gilead shared aggregate datasets at the state- and ZIP3-level with Emory. Emory then applied data suppression rules and developed the publicly available maps and data sets for AIDSVu. Please see the Data Methods page for additional information.